as on March 10, 2026 at 6:59 am IST
Day's Low
Day's High
2.34%
Downside
0.18%
Upside
52 Week's Low
52 Week's High
2.34%
Downside
35.46%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$107.6B
EPS (TTM)
5.0079
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
0.02%
PE Ratio (TTM)
19.04
Industry PE ratio
17.50525641025641
PEG Ratio
0.6779
EBITDA
12.6B
Revenue (TTM)
46.7B
Profit Margin
16.72%
Return On Equity TTM
6.66%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Industry (17.51x)
March 10, 2026
Today (19.04x)
March 10, 2026
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 19.04x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $107.6B | -7.51% | 19.04 | 16.72% | |
| BUY | $886.4B | 390.82% | 43.1 | 31.67% | |
| BUY | $301.1B | 291.39% | 29.65 | 17.41% | |
| BUY | $579.3B | 52.43% | 21.8 | 28.46% | |
| BUY | $406.9B | 110.6% | 97.09 | 6.91% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹79,969
Returns
Returns from Sanofi Stock
Dollar Returns*
₹5,192 (+5.19%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $57.68
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
23.06%UPSIDE
Target Price
$57.68
Current Price
$44.38
Analyzed by
31 Analysts
Target
$57.68
Sanofi target price $57.68, a slight upside of 23.06% compared to current price of $44.38. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has grown by 72.34% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:72.34% versus previous 30 day period
Search interest for Sanofi Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:3% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 March
Thu, 01:46 PM
-Sanofi proposes Christel Heydemann as independent director at upcoming Annual General Meeting on April 29, 2026.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, ASTRAZENECA PLC has given 156.5% return, outperforming this stock by 181.8%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 203.7% return, outperforming this stock by 209.9%
Revenue Fall
![]()
Sanofi's revenue has been declining for the past two quarters. It decreased from $13.17 billion to $12.20 billion, averaging a decline of 7.3% each quarter.
Profit Down
![]()
Sanofi's net profit has been declining for the last three quarters. It decreased from $3.94 billion to -$801 million, showing an average decrease of 78.7% each quarter.
Price Dip
![]()
In the last 7 days, SNY stock has moved down by -4.6%
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande ArmEe, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Olivier Charmeil |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Mr. Erik Wallström | Head of Therapeutic Area - Neurology Development |
Mr. Thomas Triomphe | Executive Vice President of Vaccines |
Mr. Olivier Charmeil | Interim CEO & Executive VP of General Medicines |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Mr. Thomas Kudsk Larsen | Head of Investor Relations & General Medicines |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. François-Xavier Roger | Executive VP & CFO |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Sanofi share price today is $44.38 as on at the close of the market. Sanofi share today touched a day high of $44.46 and a low of $43.34.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $43.34 on . Sanofi stock price today i.e. is closed at $44.38,which is 26.17% down from its 52 week high and 2.40% up from its 52 week low.
Sanofi market capitalisation is $0.11T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $44.38 as on March 10, 2026 at 1:29 am IST, you will get 0.2253 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -7.51% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?